Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
18/09/1990-21/02/1991
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline-compliant, GLP-compliant proprietary study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Chromoxid Extra
IUPAC Name:
Chromoxid Extra
Constituent 2
Chemical structure
Reference substance name:
Chromium (III) hydroxide
EC Number:
215-158-8
EC Name:
Chromium (III) hydroxide
Cas Number:
1308-14-1
Molecular formula:
Cr(OH)3
IUPAC Name:
1308-14-1
Details on test material:
The test material 'Chromoxid extra' is described as a dark green powder of purity 99.6%

Method

Target gene:
Reversion to histidine independence in Salmonella typhimurium
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Metabolic activation system:
Male rat liver S9 fraction (Aroclor 1254-induced)
Test concentrations with justification for top dose:
0, 8, 40 200, 1000 and 5000 ug/plate; with and without S9
Vehicle / solvent:
Deionised water
Controls
Untreated negative controls:
no
Remarks:
not required
Negative solvent / vehicle controls:
yes
Remarks:
deionised water
True negative controls:
no
Remarks:
not required
Positive controls:
yes
Remarks:
sodium azide, nitrofurantoin, 4-NPDA, 2-aminoanthracene
Details on test system and experimental conditions:
Ames test (plate incorporation assay). Triplicate plates of each strain were exposed to the test material (in deionised water) for 48 hours.
Evaluation criteria:
Negative controls within the expected range;
Positive controls showing sufficient effects;
Reproducible and dose-related increase in mutant counts of at least one strain (2x for TA1535, TA100, TA98; 3x for TA1537)
Statistics:
Not applicable

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Remarks:
Precipitation was seen at 1000 and 5000 ug/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Exposure to the test material did not induce any increase in the number of revertant colonies of any bacterial strain. Positive control compounds induced large increased in the number of revertant colonies, confirming the sensitivity of the assay.

Treatment

-S9

Initial assay

Confirmatory assay

TA98

TA100

TA1535

TA1537

TA98

TA100

TA1535

TA1537

Vehicle

20

114

12

9

34

130

15

11

8

16

125

13

9

36

123

18

9

40

26

127

15

9

34

141

20

13

200

21

133

16

7

29

138

21

12

1000

22

109

11

7

34

132

17

13

5000

20

127

12

9

34

146

21

14

Nitrofurantoin

382

416

4-NPDA

86

56

105

58

Sodium azide

631

793

+S9

Initial assay

Confirmatory assay

TA98

TA100

TA1535

TA1537

TA98

TA100

TA1535

TA1537

Vehicle

31

134

14

9

48

162

27

16

8

29

127

14

9

51

173

25

14

40

30

105

18

8

43

164

27

15

200

25

124

16

6

37

163

26

12

1000

25

125

16

9

35

174

23

14

5000

30

121

13

8

41

176

22

20

2-AA

427

817

99

134

570

1297

242

68

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative (with and without metabolic activation)

No evidence of mutagenicity was seen under the conditions of this assay.
Executive summary:

The mutagenicity of chromium hydroxide was investigated in an Ames test (plate incorporation assay) using S. typhimurium strains TA98, TA100, TA1535 and TA1537. Four replicate plates of each strain were exposed to the test material (suspended in deionised water) at concentrations of 0, 8, 40, 200, 1000 or 5000 ug/plate in the presence and absence of an exogenous metabolic activation system (Aroclor 1254 -induced male rat liver S9 fraction). There was no evidence of cytotoxicity at the limit concentration; precipitation of the test material was seen at 1000 and 5000 ug/plate. Exposure to the test material did not induce increased numbers of revertant colonies of any strain. Appropriate positive control compounds induced large increases in the numbers of revertant colonies, confirming the sensitivity of the assay. Results were confirmed in an independently-repeated assay. No evidence of mutagenicity was seen under the conditions of this study. The results of this study, performed using chromium (III) hydroxide, can be extrapolated to the similarly water-insoluble chromium (III) oxide salt.